Angiotensin-converting enzyme inhibitors: Do we utilize our knowledge in heart failure patients?

Journal of Clinical and Basic Cardiology

Volumn 4, Issue 4, 2001, Pages 279-283

  Sleiman, O ^a   Murin, Jan ^a   Ghanem, W ^a  

^a UNIVERSITY HOSPITAL BRATISLAVA   (Slovakia)

Author keywords

Angiotensin converting enzyme inhibitors; Heart failure; Mortality; Remodelling

Indexed keywords

ANGIOTENSIN ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; PERINDOPRIL; RAMIPRIL; TRANDOLAPRIL; VALSARTAN;

ANGIONEUROTIC EDEMA; CLINICAL TRIAL; COUGHING; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG USE; DYSGEUSIA; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY FAILURE; MORTALITY; PRIORITY JOURNAL; RASH; REVIEW;

EID: 0035696175     PISSN: 15612775     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Drugs for heart failure that interfere with the RAAS Heart failure
2. Effects of enalapril on mortality in severe congestive heart failure
3. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
4. Effect of enalapril on mortality and the development of HF in asymptomatic patients with reduced left ventricular ejection fractions
5. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction
6. Effect of ramipril on mortality and morbidity of survivals of acute myocardial infarction with clinical evidence of heart failure
7. A clinical trial of the ACEI trandolapril in patients with left ventricular dysfunction after myocardial infarction
8. Effect of ACEI, ramipril on cardiovascular events in high-risk patients
9. A comparison of enalapril with hydralazine-isosorbid dinitrate in the treatment of congestive heart failure
10. Failure to practice evidence-based medicine: Why do physicians not treat patients with HF with ACEIs?
11. What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity
12. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction
13. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction
14. North of England based development project: Guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure
15. Comparative effects of low and high doses of the angiotensin converting enzyme inhibitor lisinopril on morbidity and mortality in chronic heart failure
16. ACEI treatment after myocardial infarction
17. ACEIs for myocardial infarction: How should they be used?
18. ACEIs in acute myocardial infarction patient selection and timing
19. Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the captopril and thrombolysis study(CATS)
20. Captopril before reperfusion in acute myocardial infarction: The CAPTIN experience
21. Comparison of enalapril versus captopril on left ventricular function and survival three months after acute MI (the PRACTICAL study)
22. Effects of two different enalapril dosages on clinical, hemodynamic and neurohumoral response of patients with severe congestive heart failure
23. Delayed effects of one-year treatment with low-dose as compared with high-dose enalapril on morbidity and mortality of patients with severe heart failure
24. ACE inhibitor dosage at the time of listing predicts survival
25. Clinical outcome with enalopril in symptomatic chronic heart failure: A dose comparison
26. Towards the better treatment of heart failure
27. Thromboembolism in heart failure: Who should be treated?
28. Aspirin does not influence the effect of angiotensin-converting enzyme inhibition on left ventricular ejection fraction 3 months after acute myocardial infarction
29. Putting evidence into practice
30. Survival after myocardial infarction in the rat. Role of tissue ACE inhibition